Search

Amedeo A Fantini

from New City, NY
Deceased
Get Report
Also known as:
Amedeo Te Fantini, Amedeo Santini, Killian Morkin, Mike Teteryan
Phone and address:
2 The Gln, New City, NY 10956
(845) 634-5122
Related to:
Joyce A Bringenberg, 58Lawrence M Bringenberg, 59Jason Fantini, 51Jennifer Herzig, 39
Connected to:
Andrea Fantini, 37Dana R Fantini, 57Debora A Fantini, 66Dominick A Fantini, 95Lisa L Fantini, 57Mario Fantini, 97Riccardo Fantini, 54Thomas P Fantini, 69William Fantini, 66Mary G Fantino, 93

Amedeo Fantini Phones & Addresses

  • 2 The Gln, New City, NY 10956 (845) 634-5122
  • Chicago, IL
  • Ridgewood, NJ
  • New York, NY
  • Camp Douglas, WI
  • 2 The Gln, New City, NY 10956

Work

Position: Production Occupations

Business Records

Name / Title
Company / Classification
Phones & Addresses
Amedeo Fantini
Director
Biosource Pharm, Inc
Commercial Physical Research · Research & Development in Biotechnology
135 Rte 59, Chestnut Ridge, NY 10977
(845) 425-4778, (845) 425-3893

Publications

Us Patents

Derivatives Of Laspartomycin And Preparation And Use Thereof

View page
US Patent:
6511962, Jan 28, 2003
Filed:
Jan 12, 2001
Appl. No.:
09/760328
Inventors:
Donald B Borders - Suffern NY
William V Curran - Pearl River NY
Amedeo A Fantini - New City NY
Noreen D Francis - Harriman NY
Howard Jarolmen - Upper Saddle River NJ
Richard A Leese - Suffern NY
Assignee:
Micrologix Biotech Inc. - Vancouver
International Classification:
A61K 3812
US Classification:
514 11, 435 681, 435 713, 530317
Abstract:
The present invention provides a laspartomycin core peptide, a laspartomycin core peptide derivative, a antimicrobial laspartomycin derivative, a method for making laspartomycin core peptides, methods for making laspartomycin core peptide derivatives, methods for making antimicrobial laspartomycin derivatives, pharmaceutical compositions of antimicrobial laspartomycin derivatives, methods of inhibiting microbial growth and methods for treating and/or preventing microbial infections in a subject.

Extractive Purification Of Lipopeptide Antibiotics

View page
US Patent:
6716962, Apr 6, 2004
Filed:
Sep 6, 2001
Appl. No.:
09/948374
Inventors:
Donald B Borders - Suffern NY
Noreen D Francis - Harriman NY
Amedeo A Fantini - New City NY
Assignee:
Micrologix Biotech Inc. - Vancouver
International Classification:
C07K 114
US Classification:
530317, 435 713, 530323, 530344
Abstract:
The present invention provides a rapid and inexpensive method for extractively isolating acidic lipopeptide antibiotics, such as those having a cyclic peptide or cyclic depsipeptide core, in high yield and purity. In particular, there is provided a method of extracting a variety of acidic lipopeptide antibiotics, directly or indirectly, into water immiscible organic solvents by using a divalent cation chelation procedure.

Derivatives Of Laspartomycin And Preparation And Use Thereof

View page
US Patent:
6737403, May 18, 2004
Filed:
Jul 13, 2001
Appl. No.:
09/904352
Inventors:
Donald B Borders - Suffern NY
William V Curran - Pearl River NY
Amedeo A Fantini - New City NY
Noreen D Francis - Harriman NY
Howard Jarolmen - Fair Lawn NJ
Richard A Leese - Suffern NY
Assignee:
Micrologix Biotech Inc. - Vancouver
International Classification:
A61K 3812
US Classification:
514 11, 530317
Abstract:
The present invention provides laspartomycin core peptides, laspartomycin core peptide derivatives, antimicrobial laspartomycin derivatives, methods for making laspartomycin core peptides, methods for making laspartomycin core peptide derivatives, methods for making antimicrobial laspartomycin derivatives, pharmaceutical compositions of antimicrobial laspartomycin derivatives, methods of inhibiting microbial growth and methods for treating and/or preventing microbial infections in a subject.

Extractive Purification Of Lipopeptide Antibiotics

View page
US Patent:
7138487, Nov 21, 2006
Filed:
Mar 26, 2004
Appl. No.:
10/810741
Inventors:
Donald B. Borders - Suffern NY, US
Noreen D. Francis - Suffern NY, US
Amedeo A. Fantini - New City NY, US
Assignee:
Migenix Inc. - Vancouver
International Classification:
C07K 1/14
C07K 7/56
US Classification:
530317, 530344
Abstract:
The present invention provides a rapid and inexpensive method for extractively isolating acidic lipopeptide antibiotics, such as those having a cyclic peptide or cyclic depsipeptide core, in high yield and purity. In particular, there is provided a method of extracting a variety of acidic lipopeptide antibiotics, directly or indirectly, into water immiscible organic solvents by using a divalent cation chelation procedure.

Antitumor Antibiotics (Ll-E33288 Complex)

View page
US Patent:
49701983, Nov 13, 1990
Filed:
Jan 30, 1987
Appl. No.:
7/009321
Inventors:
May D. Lee - Monsey NY
Michael Greenstein - Suffern NY
David P. Labeda - Peoria IL
Amedeo A. Fantini - New City NY
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
A61K 3171
C07H 1500
US Classification:
514 25
Abstract:
Antibacterial and antitumor agents designated LL-E33288 complex and their production by new strains of Micromonospora echinospora ssp. calichensis NNRL-15839, NRRL-15975 and NRRL-18149, are disclosed.

Biologically Pure Culture Of Streptoverticillium Stramineum Sp. Nov.

View page
US Patent:
46507655, Mar 17, 1987
Filed:
Jul 30, 1985
Appl. No.:
6/760870
Inventors:
Jane P. Kirby - New City NY
Amedeo A. Fantini - New City NY
Donald B. Borders - Suffern NY
Raymond T. Testa - Cedar Grove NJ
John H. E. J. Martin - late of New City NY
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
C12P 1912
C12P 2102
US Classification:
435254
Abstract:
This invention relates to two new antibacterial and anti-tumor agents designated LL-BO1208. alpha. and LL-BO1208. beta. produced during microbiological fermentation, under controlled conditions, using the novel microorganism Streptoverticillium stramineum and mutants thereof.

Antibiotic Ll-D05139 .Beta.

View page
US Patent:
45030448, Mar 5, 1985
Filed:
Apr 25, 1983
Appl. No.:
6/488496
Inventors:
May D. Lee - Monsey NY
Donald B. Borders - Suffern NY
David P. Labeda - Monsey NY
Amedeo A. Fantini - New City NY
Raymond T. Testa - Cedar Grove NJ
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
A61K 3700
C07C10352
US Classification:
514 2
Abstract:
This disclosure describes a new antibacterial and anti-tumor agent designated LL-D05139. beta. , produced in a microbiological fermentation under controlled conditions using a new genus Glycomyces harbinensis gen. nov. , sp. nov. , and mutants thereof.

Antibiotic Ll-Bo1208.Alpha. And Ll-Bo1208.Beta., Process Of Preparation, Pharmaceutical Composition And Method Of Use

View page
US Patent:
45528675, Nov 12, 1985
Filed:
Jul 5, 1983
Appl. No.:
6/510694
Inventors:
John H. E. J. Martin - New City NY
Jane P. Kirby - New City NY
Donald B. Borders - Suffern NY
Amedeo A. Fantini - New City NY
Raymond T. Testa - Cedar Grove NJ
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
A61K 3702
A61K 3171
C12P 1912
C12P 2102
US Classification:
514 18
Abstract:
This invention relates to two new antibacterial and anti-tumor agents designated LL-BO1208. alpha. and LL-BO1208. beta. produced during microbiological fermentation, under controlled conditions, using the novel microorganism Streptoverticillium stramineum and mutants thereof.
Control profile
Amedeo A Fantini from New City, NYDeceased Get Report